Acute respiratory distress syndrome (ARDS) is a life-threatening, acute, diffuse, inflammatory form of lung damage characterized by low oxygenation, pulmonary infiltrates, and acuity of onset. ARDS is defined as an acute illness that manifests as bilateral lung infiltrates and severe progressive hypoxemia in the absence of cardiogenic pulmonary edema within 7 days after the initial event.
Patients with ARDS typically have various degrees of pulmonary artery vasoconstriction and may eventually develop pulmonary hypertension. ARDS has a significant fatality rate, and there are few effective therapeutic options available to combat it.
There are numerous risk factors for ARDS. Extra-pulmonary causes include sepsis, trauma, major transfusion, drowning, drug overdose, fat embolism, inhalation of toxic gases, and pancreatitis, in addition to pulmonary infection or aspiration. These extra-thoracic infections and/or injuries set off an inflammatory cascade that leads to pulmonary damage.
The lung injury prevention score aids in the identification of low-risk patients, although a high score is less useful.
The prevalence of ARDS in the United States is estimated to be 64.2 to 78.9 cases per 100,000 people. 25% of ARDS cases are primarily classed as mild, whereas 75% are classified as moderate or severe. However, one-third of mild cases advance to moderate to severe disease.
An analysis of the literature indicated a 1.1% annual decrease in mortality from 1994 to 2006. The overall pooled death rate for all studies reviewed, however, was 43%. ARDS mortality is proportional to illness severity; it is 27%, 32%, and 45% for mild, moderate, and severe diseases, respectively.
The severity of ARDS symptoms depends on the etiology and severity of the condition. They include -
The physical exam, chest X-ray, and oxygen levels are used to make the diagnosis. It's also critical to rule out other diseases and ailments that can cause similar symptoms, such as certain cardiac problems. These include -
Imaging
Lab Tests
Your oxygen level can be measured using blood drawn from an artery in your wrist. If your doctor suspects you have a lung infection, secretions from your airway may be analyzed to discover the cause.
Heart Tests
Treatment for ARDS typically focuses on improving blood oxygen levels, giving breathing assistance, and addressing the disease's underlying cause.
Oxygen
Medication
ARDS medication work by -
Read more such content on Hidoc Dr | Medical Learning App for Doctors
1.
FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma
2.
The Early Progression of Prostate Cancer Is Not Stopped by Metformin.
3.
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
4.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
5.
Tipiracil hydrochloride and trifluridine tablets are approved by the USFDA for Natco Pharma.
1.
Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction
2.
Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication
3.
Understanding Iron Saturation Levels in Your Blood
4.
Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology
5.
Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
3.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
4.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation